Remove 2023 Remove Compounding Remove Controlled Substances
article thumbnail

Uh Oh, A Controlled Substance Bottle Spilled or Broke. Now What?

epicur

Have you ever broken or spilled a bottle of a controlled substance? 5 Reminders for Properly Documenting a Spilled or Broken Bottle of a Controlled Substance A spill or breakage does not constitute a loss because the registrant can account for the controlled substance. If so, did you document it?

article thumbnail

Rite Aid’s Closing and Bankruptcy: The Full Story!

The Happy PharmD

Despite its substantial revenue of $24 billion in 2023, Rite Aid faced a steady decline leading to its eventual bankruptcy filing. Compounding its challenges, Rite Aid became entangled in legal issues, notably linked to the opioid crisis.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmacies Selling PSE: Remember to Train Employees and Self-Certify

FDA Law Blog: Biosimilars

Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). 16, 2023 ( DOJ Press Release ).

article thumbnail

Joint Basis for FDA/HHS Marijuana Rescheduling Recommendation Unveiled

FDA Law Blog: Biosimilars

Houck — In August 2023 the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. By Larry K.

article thumbnail

Protecting Public Health through Accreditations and Inspections 

National Association of Boards of Pharmacy

The major components that the team looks for during a site visit are: controlled substance security, temperature control, cleanliness, business continuity and disaster planning, and who the business is buying from and selling to.

article thumbnail

Blood Sugar, Hashimoto’s, Ozempic, Metformin and Berberine

The Thyroid Pharmacist

A 2023 study found that using these drugs for one to three years was associated with a 58 percent increased risk of all thyroid cancers, and a 78 percent increased risk of medullary thyroid cancer [20] As a pharmacist, I can appreciate why such a profile has made this drug the next blockbuster. Published 2023 Sep 27. June 1, 2023.

article thumbnail

Marijuana: Top Ten Reasons for Descheduling, Rescheduling or Not

FDA Law Blog: Biosimilars

We blogged on the December 5, 2023, letter from six Democratic governors to President Biden). The three letters together provide the range of actions DEA may take: no rescheduling from schedule I (former drug officials), rescheduling to schedule III (Democratic state attorneys general), or descheduling altogether (Democratic senators). (We